Page last updated: 2024-10-25

deferoxamine and Erythrocytosis

deferoxamine has been researched along with Erythrocytosis in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BETETTO, D1
CRISTINA, P1
CAPPELLETTI, S1
FIELDING, J1

Other Studies

2 other studies available for deferoxamine and Erythrocytosis

ArticleYear
[PRELIMINARY RESULTS ON THE USE OF DESFERRIOXAMINE IN POLYCYTHEMIA].
    Haematologica, 1963, Volume: 48

    Topics: Alcoholism; Biomedical Research; Deferoxamine; Humans; Hydroxamic Acids; Iron; Liver Cirrhosis; Poly

1963
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
    Journal of clinical pathology, 1965, Volume: 18

    Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami

1965